As the world is focused on the war in Ukraine, Big Pharma company Pfizer quietly released documents that the Food and Drug Administration wanted to be sealed until 2097. The FDA came into [.]
about their new belgioioso® fresh mozzarella, made by artisan cheesemakers. hold up! let s go faster. -with fresh milk from america s dairyland, wisconsin. man, wisconsin people love cheese. it s great on e new turkey cali fresh. les go faster. the eat fresh refresh at subway®. it s too much new to fit in one commerc- welcome back. w developments today in the effort to get children vaccinated against the coronavirus. pfizer announced this morning it has submitted its vaccine trial data for kids ages 5 to 11 to the fda. dr. fauci addressed the news this morning. the fda, you never want to get ahead of their judgment, but i imagine in the next few weeks they ll examine that data and hopefully give the okay so we can start vaccinating hopefully before the end of october. hospitalizations among young people are surging across ohio.
transmission in the schools. so what s happening now is kids are coming home, infecting their parents. parents are infecting their kids. kids are infecting each other. it s making it impossible to get our kids through the school year so vaccines would get our kids through the school year and ultimately if we re serious about halting this epidemic in the united states, we need 85% to 90% of the u.s. population vaccinated. that means all of the adults, all of the ads olescents and lae numbers of kids. those are the three goals i see. this vaccine trial data for pfizer is just for kids aged 5 to 11. why did they limit it to that age group? what s the difference between vaccinating a 4-year-old and 5-year-old? well, it s not so much that, but this is pretty standard in vaccine development that we do step down studies. so you start with the adults. then pivot to the teenagers, adolescents and then start moving to younger age groups in segments.
Daily Crunch: Robinhood raises $1B yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
U.S. stock indexes dropped, closing out the Friday session with the biggest weekly fall since October, as investors gauged the ramifications of Johnson & Johnson's COVID-19 vaccine trial results, while a standoff between Wall Street hedge funds and small, retail investors added to volatility. Johnson & Johnson fell 3.56% as one of the biggest weights on both the Dow and S&P500 after the drugmaker said its single-dose vaccine was 72% effective in preventing COVID-19 in the United States, with a lower rate of 66% observed globally.